Any thoughts on Accelerated Approval? I would imagine that they would have to be looking at it after today.
The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and that fill an unmet medical need based on a surrogate endpoint. A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. The use of a surrogate endpoint can considerably shorten the time required prior to receiving FDA approval.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial
Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-50
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.8¢ |
Change
0.008(3.41%) |
Mkt cap ! $79.57M |
Open | High | Low | Value | Volume |
22.5¢ | 23.5¢ | 22.5¢ | $18.31K | 80.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 151703 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 130080 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 150174 | 0.225 |
12 | 94485 | 0.220 |
7 | 98958 | 0.215 |
5 | 131050 | 0.210 |
4 | 104982 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 130080 | 2 |
0.235 | 139523 | 8 |
0.240 | 40833 | 1 |
0.250 | 15000 | 1 |
0.255 | 9785 | 1 |
Last trade - 13.55pm 15/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online